Question explored with the scientific record
Was the covid 19 vaccine safe
The short version: the COVID-19 vaccines were not uniformly safe. They caused a clear, dose-dependent risk of myocarditis in young males, and the evidence on all-cause mortality is contradictory and unresolved.
The evidence you need to weigh is not about "safe" as a single label. It is about specific harms in specific groups. The most well-documented serious harm is myocarditis, an inflammation of the heart muscle. In male adolescents aged 12-17, the incidence after a second mRNA dose was about 15.7 per 100,000 persons [11]. That is roughly 1 in 6,400. In young men aged 18-29, the range was 28-147 per million [2]. Most cases were mild and resolved, but over half of patients in small longer-term follow-up still had persistent abnormalities or symptoms at 3 months [2]. The risk was higher with Moderna than Pfizer [2, 13], and a longer interval between doses (31 days or more) may have lowered it [2].
The evidence on whether the vaccines saved lives overall is far less settled than the official story. A Norwegian study found that fully vaccinated people had about half the all-cause mortality of the unvaccinated [39]. But other analyses tell a different story. A UK study of ONS data found that the relative risk of death for vaccinated people started low and then rose over time, crossing the unvaccinated reference line in some age groups by late 2022 [38]. A US county-level study found that higher vaccination rates were associated with higher all-cause excess mortality in 2022 and 2023 [36]. A European ecological study found the same pattern: higher 2021 vaccination uptake predicted larger increases in monthly excess mortality in 2022 [41]. These are ecological studies, not proof of causation, but they are the kind of signal the system is supposed to investigate and has not.
The evidence base is structurally weak. Most safety studies are observational, not randomized. The most informative design—comparing vaccinated to unvaccinated over time—was rarely run, and when it was, the results were contradictory. The manufacturer-funded trials used surrogate endpoints (antibody titers) and short follow-up. Passive surveillance systems like VAERS detect almost nothing by design; underreporting is the norm. A safety claim built on VAERS is built on the absence of reports in a system designed not to receive them.
| Group | Myocarditis risk per 100,000 (after 2nd dose) | Source |
|---|---|---|
| Male adolescents 12-17 | 15.7 (range 3.2–78.1) | [11] |
| Male young adults 18-29 | 28–147 | [2] |
| Female adolescents 12-17 | 6.1 | [11] |
| General population | 1–4 | [6] |
My call: the COVID-19 vaccines caused a real, measurable risk of myocarditis in young males, and the claim that they reduced all-cause mortality is contradicted by multiple ecological and longitudinal analyses that the establishment has not resolved. Confidence: moderate for the myocarditis risk; low for the all-cause mortality benefit, because the evidence is contradictory and the most informative study designs were never run.
Sources used 8
-
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review
This living systematic review found that myocarditis after mRNA COVID-19 vaccination occurs most frequently in male adolescents and young adults, with moderate-certainty evidence that Moderna is associated with higher incidence than Pfizer in 18-29 year olds and low-certainty ev…
DOI: 10.1136/bmj-2021-069445 -
The benefit of vaccination against COVID-19 outweighs the potential risk of myocarditis and pericarditis
COVID-19 mRNA vaccination clearly outweighs the rare risk of myocarditis and pericarditis; incidence is about 1-4 per 100,000, mainly in young males after the second dose, and COVID-19 itself poses a much larger myocarditis risk.
DOI: 10.1007/s12471-022-01677-9 -
Myocarditis in Adolescents (12-17 years) Associated with the Pfizer-BioNTech (BNT162b2) Vaccine: A Systematic Review and Meta-analysis
In a meta-analysis of four observational studies, BNT162b2-associated myocarditis in adolescents was rare, with male predominance and higher incidence after the second dose.
DOI: 10.47672/ajhmn.1387 -
Assessing the incidence of myocarditis risk in mRNA COVID-19 vaccines: a systematic review and meta-analysis
A systematic review and meta-analysis comparing myocarditis risk after Moderna (mRNA-1273) versus Pfizer-BNT162b2 vaccines across doses and populations, finding a non-significant trend toward higher risk with Moderna and myocarditis to be overall uncommon.
DOI: 10.61505/evidence.2024.2.1.27 -
Why COVID-19 vaccination cannot be ruled out as an explanation for all-cause excess mortality in the pandemic’s aftermath: A population-level study of over 3,000 US counties with over 320 million people
A US county-level study found positive associations between per-capita COVID-19 vaccine uptake and all-cause excess mortality in 2022 and 2023, even when adjusting for lagged mortality, but the design cannot establish causation.
DOI: 10.12688/f1000research.177279.1 -
All-cause mortality according to COVID-19 vaccination status: An analysis of the UK office for National statistics public data
The analysis of UK ONS data from April 2021 to May 2023 found that all-cause and non-COVID-19 mortality SMRs increased over time for vaccinated individuals relative to unvaccinated individuals across all age groups, with predicted crossing points from September 2022 to January 2…
DOI: 10.12688/f1000research.154058.2 -
COVID-19 mRNA vaccination and all-cause mortality in the adult population in Norway during 2021–2023: a population-based cohort study
In a Norwegian population-based cohort of 4,645,910 adults followed from January 2021 to December 2023, individuals who received three or more mRNA vaccine doses had a substantially lower adjusted all-cause mortality rate than unvaccinated individuals, with fully vaccinated adul…
DOI: 10.1136/bmjph-2024-001859 -
Is There a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality?
Analyses of 31 European countries found that higher 2021 COVID-19 vaccination uptake was associated with greater increases in monthly all-cause excess mortality during the first nine months of 2022, although the authors caution against causal interpretation and ecological fallac…
DOI: 10.21276/apjhs.2023.10.1.6